No Detail Found!

Effect of ketogenic diet plus dulaglutide on glucose and lipid metabolism in diabetes mellitus

Author(s)
Rui Gao Department of Outpatient, Affiliated Hospital of Hebei University,Baoding, Hebei,China
Lu Yan Department of Outpatient, Affiliated Hospital of Hebei University,Baoding, Hebei,China
Xuerun Du Department of Outpatient, Affiliated Hospital of Hebei University,Baoding, Hebei,China
Shuqing He Department of Outpatient, Affiliated Hospital of Hebei University,Baoding, Hebei,China
Lei Xue Department of Outpatient, Affiliated Hospital of Hebei University,Baoding, Hebei,China
Tingting Li Department of Thoracic Surgery, Affiliated Hospital of Hebei University,Baoding, Hebei,China
Minxiang Wei Department of Breast Surgery, Affiliated Hospital of Hebei University,Baoding, Hebei,China
Yujie Gu Department of Endocrinology, Affiliated Hospital of Hebei University,Baoding, Hebei,China
Abstract
Diabetes mellitus is a chronic disease with a high incidence worldwide and exclusive drug treatment has a limited effect. To investigate the effects of a ketogenic diet combined with dulaglutide on glucose and lipid metabolism in diabetic patients, a total of 104 patients with type 2 diabetes mellitus were randomly divided into a study group (dulaglutide + ketogenic diet) and a control group (dulaglutide). The results showed that, in comparison with the control group, the blood glucose and blood lipid levels in the study group were lower than those in the control group after treatment (P<0.05). The insulin resistance index of the study group was decreased and the insulin sensitivity index was increased (P<0.05). At the 6-month follow-up, the Pittsburgh Sleep Quality Index score was lower and the quality of life was better in the study group (P<0.05). In conclusion, thevketogenic diet combined with dulaglutide can effectively improve glucose and lipid metabolism, insulin function and quality of life in diabetes mellitus patients. .
Publication Details
Page(s) 2286-2291
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
ketogenic diet, Diabetes mellitus, Diabetes mellitus, Dulaglutide, Glycolipid metabolism
References
Abbasi-Ghahramanloo A,Soltani-Kermanshahi M,Mansori K,Khazaei-Pool M,Sohrabi M,Baradaran HR,Talebloo Z,Gholami A .2020 .Comparison of SF36 and WHOQoL-BREF in measuring quality of life in patients with type 2 diabetes. Int. J. Gen. Med, 13 : 497-506.
Attia SM,Alshamrani AA,Ahmad SF,Albekairi NA,Nadeem A,Attia MSM,Ansari MA,Almutairi F,Bakheet SA .2024 .Dulaglutide reduces oxidative DNA damage and hypermethylation in the somatic cells of mice fed a high-energy diet by restoring redox balance, inflammatory responses and DNA repair gene expressions. J. Biochem. Mol. Toxicol, 38(7) : e23764.
Chen L,Liu B,Ren L,Du H,Fei C,Qian C,Li B,Zhang R,Liu H,Li Z .2023 .High-fiber diet ameliorates gut microbiota, serum metabolism and emotional mood in type 2 diabetes patients. Front. Cell. Infect. Microbiol., 13 : 1069954.
Choy KYC,Louie JCY .2023 .The effects of the ketogenic diet for the management of type 2 diabetes mellitus: A systematic review and meta-analysis of recent studies. Diabetes. Metab. Syndr., 17(12) : 102905.
Darenskaya MA,Kolesnikova LI,Kolesnikov SI .2021 .Oxidative stress: Pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull. Exp. Biol. Med, 171(2) : 179-189.
Dashti HM,Mathew TC,Al-Zaid NS .2021 .Efficacy of low-carbohydrate ketogenic diet in the treatment of type 2 diabetes. Med, 30(3) : 223-235.
El Karkafi R,Gebara T,Salem M,Kamel J,El Khoury G,Zalal M,Fakhoury M M .2023 .Ketogenic diet and inflammation: Implications for mood and anxiety disorders. Adv. Exp. Med, 1411 : 537-554.
Faselis C,Katsimardou A,Imprialos K,Deligkaris P,Kallistratos M,Dimitriadis K M .2020 .Microvascular complications of type 2 diabetes mellitus. Curr. Vasc. Pharmacol., 18(2) : 117-124.
Fralick M,Jenkins AJ,Khunti K,Mbanya JC,Mohan V,Schmidt MI .2022 .Global accessibility of therapeutics for diabetes mellitus. Nat. Rev. Endocrinol., 18(4) : 199-204.
Gardner CD,Landry MJ,Perelman D,Petlura C,Durand LR,Aronica L,Crimarco A,Cunanan KM,Chang A,Dant CC,Robinson JL,Kim SH .2022 .Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: The interventional Keto-Med randomized crossover trial. Am. J. Clin. Nutr, 116(3) : 640-652.
Glenn AJ,Li J,Lo K,Jenkins DJA,Boucher BA,Hanley AJ,Kendall CWC,Shadyab AH,Tinker LF,Chessler SD,Howard BV,Liu S,Sievenpiper JL S .2023 .The portfolio diet and incident type 2 diabetes: Findings from the women's health initiative prospective cohort study. Diabetes. care., 46(1) : 28-37.
Ikegami H,Hiromine Y,Noso S Y .2022 .Insulindependent diabetes mellitus in older adults: Current status and future prospects. Geriatr. Gerontol. Int., 22(8) : 549-553.
Kosmalski M,Frankowski R,Ró życkaKosmalska M and Pietras S,T S .1852 .What's new in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). J. Clin. Med, 12 : .
Lovic D,Piperidou A,Zografou I,Grassos H,Pittaras A,Manolis A .2020 .The growing epidemic of diabetes mellitus. Curr. Vasc. Pharmacol., 18(2) : 104-109.
Maselli DB,Camilleri M .2021 .Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity. Adv. Exp. Med, 1307 : 171-192.
Nauck MA,Quast DR,Wefers J,Meier JJ .2021 .GLP1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Mol. Metab, 46 : 101102.
Norwitz NG,Sethi S,Palmer CM .2020 .Ketogenic diet as a metabolic treatment for mental illness. Curr. Opin. Endocrinol. Diabetes. Obes., 27(5) : 269-274.
Park BK .2020 .The Pittsburg Sleep Quality Index (PSQI) and associated factors in middle-school students: A cross-sectional study. Child. Health. Nurs. Res., 26(1) : 55-63.
Perlman J,Wetmore E,Lehner-Gulotta D,Banwell B,Bergqvist AGC,Coleman R,Chen S,Conaway M,Goldman MD,Morse AM,Brenton JN .2024 .Impact of a ketogenic diet on sleep quality in people with relapsing multiple sclerosis. Sleep Med, 122 : 213-220.
Shand JAD,Young S,Verster F,Peters C .2023 .Pilot study to test the safety, tolerability and feasibility of dulaglutide during a low-energy diet for weight loss and improved glycaemic control. BMJ. Nutr, 6(2) : 341-346.
Yabe D,Kawamori D,Seino Y,Oura T,Takeuchi M .2023 .Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy). Diabetes. Obes. Metab., 25(2) : 398-406.
Yang X,Zhou J,Shao H,Huang B,Kang X,Wu R,Bian F,Hu M,Liu D M .2023 .Effect of an intermittent calorie-restricted diet on type 2 diabetes remission: A randomized controlled trial. J. Clin. Endocrinol. Metab., 108(6) : 1415-1424.
Zhang Y,Qu Z,Lu T,Shao X,Cai M,Dilimulati D,Gao X,Mao W,Hu F,Su L,Liao Q,Han T,Zhang M,Qu S M .2023 .Effects of a dulaglutide plus calorie-restricted diet versus a calorie-restricted diet on visceral fat and metabolic profiles in women with polycystic ovary syndrome: A randomized controlled trial. Nutrients., 15(3) : 556.
0

Citations

0

Downloads

72

Views